| Product NDC: | 51079-323 |
| Proprietary Name: | Anastrozole |
| Non Proprietary Name: | anastrozole |
| Active Ingredient(s): | 1 mg/1 & nbsp; anastrozole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51079-323 |
| Labeler Name: | UDL Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091051 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100723 |
| Package NDC: | 51079-323-06 |
| Package Description: | 50 BLISTER PACK in 1 BOTTLE, UNIT-DOSE (51079-323-06) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-323-01) |
| NDC Code | 51079-323-06 |
| Proprietary Name | Anastrozole |
| Package Description | 50 BLISTER PACK in 1 BOTTLE, UNIT-DOSE (51079-323-06) > 1 TABLET, FILM COATED in 1 BLISTER PACK (51079-323-01) |
| Product NDC | 51079-323 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | anastrozole |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20100723 |
| Marketing Category Name | ANDA |
| Labeler Name | UDL Laboratories, Inc. |
| Substance Name | ANASTROZOLE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |